🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 11 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/03/2001 | 7,50 | 7,50 | 7,00 | 7,03 | -4,66% | 6,67% | 543.600 |
| 09/03/2001 | 7,30 | 7,69 | 7,00 | 7,38 | +5,36% | 9,41% | 766.000 |
| 08/03/2001 | 6,93 | 7,25 | 6,81 | 7,00 | +3,23% | 6,31% | 601.600 |
| 07/03/2001 | 6,47 | 6,88 | 6,31 | 6,78 | +5,34% | 8,70% | 513.800 |
| 06/03/2001 | 6,55 | 6,72 | 6,19 | 6,44 | +2,49% | 8,11% | 572.400 |
| 05/03/2001 | 6,51 | 7,13 | 6,25 | 6,28 | -3,36% | 13,45% | 155.600 |
| 02/03/2001 | 6,47 | 7,38 | 6,44 | 6,50 | +0,97% | 14,49% | 663.600 |
| 01/03/2001 | 6,06 | 6,81 | 6,00 | 6,44 | +6,19% | 13,40% | 813.800 |
| 28/02/2001 | 5,56 | 6,06 | 5,38 | 6,06 | +11,02% | 12,36% | 1.104.400 |
| 27/02/2001 | 6,02 | 6,03 | 5,25 | 5,46 | -8,03% | 12,97% | 478.200 |
| 26/02/2001 | 6,06 | 6,06 | 5,81 | 5,94 | -1,04% | 4,12% | 206.400 |
| 23/02/2001 | 6,16 | 6,25 | 5,72 | 6,00 | -2,04% | 8,63% | 253.000 |
| 22/02/2001 | 6,69 | 6,69 | 5,84 | 6,13 | -7,55% | 12,62% | 176.000 |
| 21/02/2001 | 7,03 | 7,03 | 6,63 | 6,63 | -2,30% | 5,78% | 247.400 |
| 20/02/2001 | 6,88 | 6,88 | 6,75 | 6,78 | +0,46% | 1,82% | 134.200 |
| 16/02/2001 | 7,09 | 7,09 | 6,75 | 6,75 | -1,59% | 4,74% | 135.600 |
| 15/02/2001 | 7,03 | 7,03 | 6,75 | 6,86 | -0,68% | 4,00% | 250.000 |
| 14/02/2001 | 6,89 | 7,00 | 6,78 | 6,91 | -0,45% | 3,17% | 163.000 |
| 13/02/2001 | 7,25 | 7,25 | 6,88 | 6,94 | -2,63% | 5,17% | 121.000 |
| 12/02/2001 | 7,00 | 7,22 | 6,88 | 7,13 | +1,79% | 4,91% | 147.000 |
| 09/02/2001 | 7,06 | 7,09 | 6,66 | 7,00 | +0,45% | 6,19% | 153.000 |
| 08/02/2001 | 7,25 | 7,31 | 6,78 | 6,97 | -2,62% | 7,33% | 105.400 |
| 07/02/2001 | 7,31 | 7,31 | 6,66 | 7,16 | -0,87% | 8,97% | 202.600 |
| 06/02/2001 | 7,31 | 7,38 | 7,00 | 7,22 | -1,28% | 5,13% | 166.000 |
| 05/02/2001 | 7,63 | 7,63 | 7,03 | 7,31 | -2,09% | 7,79% | 147.600 |
| 02/02/2001 | 8,05 | 8,05 | 7,47 | 7,47 | -5,90% | 7,18% | 248.000 |
| 01/02/2001 | 8,29 | 8,31 | 7,94 | 7,94 | -0,78% | 4,52% | 341.800 |
| 31/01/2001 | 7,78 | 8,28 | 7,75 | 8,00 | +4,49% | 6,83% | 337.800 |
| 30/01/2001 | 7,70 | 7,81 | 7,63 | 7,66 | +0,41% | 2,44% | 384.800 |
| 29/01/2001 | 7,66 | 7,69 | 7,11 | 7,63 | +0,00% | 7,55% | 359.000 |